ReTo Eco-Solutions, Inc. Announces Acquisition of Majority Interest in MeinMalzeBier Holdings Limited
BEIJING, April 25, 2025 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company"), a manufacturer of ecological environment protection equipment and intelligent equipment in China, today announced that on April 25, 2025, it...
Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Solid Tumors
CHENGDU, China, April 25, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced CM518D1, a CDH17-targeted antibody-drug conjugate (ADC) developed by Keymed, received Investigational New Drug (IND)...
Announcement of Paper Publication: EditForce Demonstrates Efficacy of Treatment for Myotonic Dystrophy Type 1 Using PPR Platform Technology
FUKUOKA, Japan, April 25, 2025 /PRNewswire/ -- EditForce, Inc. (Headquarters: Fukuoka, Japan) is pleased to announce that a research paper on the results of a joint study with the research group led by Professor Masayuki Nakamori of the Department...
LianLian Global Announces Strategic Partnerships with Veem and 12Victory at Money20/20 Asia
Cross-border payments platform outlines global expansion strategy and unveils new real-time remittance and B2B solutions BANGKOK, April 25, 2025 /PRNewswire/ -- LianLian Global, a flagship brand of Hong Kong-listed digital payments provider Lianlian...
Yutong Bus Announces Major Milestone for "Net Zero Forest" Initiative on Earth Day 2025: One Tree Planted per Bus in Operation
Pioneering Sustainability Program Integrates Green Mobility with Ecological Restoration, Reinforcing Leadership in Low-Carbon Innovation ZHENGZHOU, China, April 25, 2025 /PRNewswire/ -- Yutong Bus ("Yutong", SHA: 600066), a commercial vehicle...
Akeso Announces FDA Approval for Penpulimab-kcqx in Two BLA Indications for Comprehensive Treatment of Advanced Nasopharyngeal Carcinoma
HONG KONG, April 25, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the U.S. Food and Drug Administration (FDA) has approved its differentiated PD-1 monoclonal antibody, penpulimab-kcqx, in...
VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Non-Infectious Anterior Uveitis
VVN461, a dual JAK1/TYK2 inhibitor as a non-steroidal anti-inflammatory agent, has met primary endpoints, demonstrating non-inferior efficacy compared to the standard therapy, prednisolone acetate (PA) in treating NIAU Clinically meaningful...
Newborn Town Announces Q1 2025 Operating dаta: Revenue Expected to Exceed RMB 1,500 Million, Up 41.5% to 48.1 %, Fueled by Explosive Growth in Social and Innovative Businesses
HONG KONG, April 24, 2025 /PRNewswire/ -- Newborn Town Inc. (Newborn Town or the company, stock code: 09911.HK), a leading global social entertainment company, released its unaudited operating data for the first quarter of 2025. For the three months...
MINISO Group Announces Annual General Meeting on June 12, 2025, Filing of Annual Report on Form 20-F and Proposed Change of Auditors
GUANGZHOU, China, April 24, 2025 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO", "MINISO Group" or the "Company"), a global value retailer offering a variety of trendy lifestyle products featuring IP design, today...
NaaS Technology Inc. Announces Plan to Implement ADS Ratio Change
BEIJING, April 24, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that that it will change the ratio of its American Depositary Shares...